Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

Springer Science and Business Media LLC - Tập 13 Số 4 - Trang 219-227 - 2005
Charlotte C. Sun1, Diane C. Bodurka1, C. B. Weaver1, Rafia S. Rasu1, Judith K. Wolf1, Michael W. Bevers1, Judith A. Smith1, J. Taylor Wharton1, Edward Rubenstein2
1Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 440, Houston, USA
2Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Unit 8, Houston, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Agarwal R, Kaye SG (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3:502?516

Borjeson S, Hursti T, Peterson C, Fredikson M, Furst CJ, Avall-Lundqvist E, Steineck G (1997) Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale. Cancer Nurs 20(4):260?266

Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D (2002) Changing patient perceptions of the side effects of chemotherapy. Cancer 95:155?163

Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MHN (1983) On the receiving end?patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203?208

de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, Verweij J (1997) Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 76(8):1055?1061

Drummond MF, O?Brien B, Stoddart GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes (2nd edn). Oxford University Press, New York

Griffen AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MHN (1996) On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189?195

Grunberg SM, Boutin N, Ireland A, Miner S, Silveira J, Ashikaga T (1996) Impact of nausea/vomiting on quality of life as a visual analogue scale-derived utility score. Support Care Cancer 4:435?439

Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, Adkins S, Sawyer WT (1999) Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Practice 7(2):59?65

McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Practice 9(6):283?289

Moss C, Kaye SB (2002) Ovarian cancer: progress and continuing controversies in management. Eur J Cancer 38:1701?1707

Münstedt K, Manthey N, Sachsse S, Vahrson H (1997) Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 5:139?143

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326?1336

Stiggelbout AM, De Haes JCJM (2001) Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol 19:220?230

Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM (2002) Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol 87:118?128

Torrance GW, Feeny D, Furlong W (2001) Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making 21:329?334